Clinical Trials · NCT06411366
Phase I: Safety and Efficacy of an Injectable Follistatin Plasmid Gene Therapy in Humans
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Minicircle
- Enrollment
- 43
- Start date
- Aug 2022
- Locations
- 1 site, Honduras
- Primary endpoint
- Number of Participants With Treatment-Related Adverse Events as Assessed by CTCAE v4.0